We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTIP icon
4676
Network-1 Technologies
NTIP
$36.1M
$2.15K ﹤0.01%
1,435
-918
-39% -$1.33K
DRMA icon
4677
Dermata Therapeutics
DRMA
$4.5M
$2.14K ﹤0.01%
426
-106
-20% -$644
BQ
4678
Boqii Holding Ltd
BQ
$6.05M
$2.13K ﹤0.01%
+221
New +$673
BAP icon
4679
Credicorp
BAP
$30.4B
$2.13K ﹤0.01%
8
-340
-98% -$84.1K
BEAT icon
4680
Heartbeam
BEAT
$30.5M
$2.13K ﹤0.01%
1,288
-1,272
-50% -$1.64K
ANVS icon
4681
Annovis Bio
ANVS
$80.4M
$2.11K ﹤0.01%
+1,021
New +$2.55K
BOTJ icon
4682
Bank Of The James
BOTJ
$123M
$2.11K ﹤0.01%
135
-158
-54% -$2.31K
KNSA icon
4683
Kiniksa Pharmaceuticals
KNSA
$5.97B
$2.1K ﹤0.01%
54
-25,221
-100% -$819K
APVO icon
4684
Aptevo Therapeutics
APVO
$5.01M
$2.1K ﹤0.01%
80
+14
+21% +$562
IMDX
4685
Insight Molecular Diagnostics
IMDX
$154M
$2.07K ﹤0.01%
624
-3,844
-86% -$10.8K
NIU
4686
Niu Technologies
NIU
$160M
$2.06K ﹤0.01%
+440
New +$1.79K
VOT icon
4687
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.7B
$2.06K ﹤0.01%
+7
New +$2.02K
CALC icon
4688
CalciMedica
CALC
$10.4M
$2.05K ﹤0.01%
666
-2,327
-78% -$6.7K
BIRD icon
4689
Smartbird Inc
BIRD
$22.7M
$2.05K ﹤0.01%
361
+261
+261% +$2.15K
DLHC icon
4690
DLH Holdings
DLHC
$70.2M
$2.04K ﹤0.01%
362
-422
-54% -$2.38K
UONE icon
4691
Urban One Class A
UONE
$24.4M
$2.04K ﹤0.01%
147
+50
+52% +$809
REFR icon
4692
Research Frontiers
REFR
$17.1M
$2.04K ﹤0.01%
1,282
-786
-38% -$1.19K
MBIO icon
4693
Mustang Bio
MBIO
$4.47M
$2.02K ﹤0.01%
1,332
-2,646
-67% -$4.7K
SCYX icon
4694
SCYNEXIS
SCYX
$51.2M
$2.02K ﹤0.01%
329
-440
-57% -$2.98K
FIG
4695
Figma
FIG
$13.5B
$2.02K ﹤0.01%
+39
New +$2.68K
RDIB
4696
Reading International Class B
RDIB
$204M
$2.02K ﹤0.01%
+181
New +$2.05K
RNXT icon
4697
RenovoRx
RNXT
$52.3M
$2.02K ﹤0.01%
+1,589
New +$1.89K
DAO
4698
Youdao
DAO
$2.19B
$2.01K ﹤0.01%
202
-500
-71% -$4.46K
BSIN
4699
Big Sky Industrial
BSIN
$63.3M
$1.99K ﹤0.01%
1,688
-10,924
-87% -$13.3K
VEEA
4700
Veea Inc
VEEA
$8.68M
$1.99K ﹤0.01%
3,188
+2,478
+349% +$2.63K

Similar funds

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.